Company Thyrocare Technologies Limited

Equities

THYROCARE

INE594H01019

Healthcare Facilities & Services

Market Closed - Bombay S.E. Other stock markets 06:00:49 2026-03-13 am EDT			5-day change	1st Jan Change
354.70 ^INR	-3.25%		-5.26%	-20.47%

Feb. 23	Thyrocare Laboratories Limited announced that it has received $0.475 million in funding from Thyrocare Technologies Limited	CI
Jan. 28	Thyrocare Technologies Limited, Q3 2026 Earnings Call, Jan 28, 2026

Business description: Thyrocare Technologies Limited

Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It conducts an array of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include diagnostic testing services, imaging services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radiopharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It is also focused on offering pathological services.

Number of employees: 1,822

Sales by Activity: Thyrocare Technologies Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Diagnostic Testing Services	4.73B	5.55B	4.81B	5.22B	6.3B
Imaging Services	204M	273M	402M	476M	543M
Others	13.4M	61.6M	52.4M	20.5M	33.7M

See all business segments

Geographical breakdown of sales: Thyrocare Technologies Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
India	4.95B	5.89B	5.27B	5.72B	6.87B

See all geographic segments

Executive Committee: Thyrocare Technologies Limited

Manager	Title	Age	Since
Rahul Franklin Guha CEO	Chief Executive Officer	-	2022-05-03
Brijesh Kumar CMP	Compliance Officer	-	2025-01-30

See THYROCARE TECHNOLOGIES LIMITED governance

Composition of the Board of Directors: Thyrocare Technologies Limited

Director	Title	Age	Since
Indumathi Gopinathan BRD	Director/Board Member	-	2017-08-11
Dharmil Nirupam Sheth BRD	Director/Board Member	37	2021-08-31
Rahul Franklin Guha BRD	Director/Board Member	-	2022-05-03
Dhaval Rajesh Shah BRD	Director/Board Member	-	2021-10-05
Prapti Ishwar Gilada BRD	Director/Board Member	-	2023-07-13
Harshil Jiten Vora BRD	Director/Board Member	-	2023-07-13
Alok Kumar Jagnani BRD	Director/Board Member	-	2025-07-23
Tarun Khanna BRD	Director/Board Member	54	-

Composition of the Board of Directors

Shareholders: Thyrocare Technologies Limited

Name	Equities	%	Valuation
Docon Technologies Pvt Ltd. 60.93 %	96,969,696	60.93 %	421 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt) 6.006 %	9,559,923	6.006 %	41 M ₹
HSBC Asset Management (India) Pvt Ltd. 3.839 %	6,110,670	3.839 %	27 M ₹
Aditya Birla Sun Life Amc Ltd. (Investment Management) 2.704 %	4,303,028	2.704 %	19 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt) 0.8978 %	1,428,950	0.8978 %	6 M ₹

List of THYROCARE TECHNOLOGIES LIMITED shareholders

Company details: Thyrocare Technologies Limited

Thyrocare Technologies Ltd.

MIDC Turbhe

400703, Navi Mumbai

+91 22 3090 0000

http://www.thyrocare.com

address Thyrocare Technologies Limited(THYROCARE)

Medical & Diagnostic Laboratories

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
THYROCARE TECHNOLOGIES LIMITED	-3.25%	-5.26%	+57.93%	+122.80%	632M
NATERA, INC.	-0.96%	-4.97%	+32.12%	+241.21%	26.97B
SONIC HEALTHCARE LIMITED	+0.43%	-8.62%	-17.51%	-37.37%	7.4B
RADNET, INC.	+3.22%	+0.87%	+33.29%	+162.57%	4.64B
DR. LAL PATHLABS LIMITED	-1.59%	+1.19%	+7.41%	+48.05%	2.49B
GENEDX HOLDINGS CORP.	-0.51%	-13.23%	-14.41%	+536.45%	2.25B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-1.34%	-1.03%	-22.86%	-64.96%	1.91B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-1.37%	-3.12%	+16.63%	-21.86%	1.82B
FLEURY S.A.	-6.01%	-3.56%	+37.33%	+11.19%	1.64B
H.U. GROUP HOLDINGS, INC.	-0.59%	-7.84%	+12.43%	+9.10%	1.07B
Average	-1.24%	-4.27%	+14.23%	+100.72%	5.08B
Weighted average by Cap.	-0.73%	-4.66%	+19.18%	+162.38%